SARS-CoV-2 viability on different surfaces after gaseous ozone treatment: a preliminary evaluation.


Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 30 10 2020
revised: 19 01 2021
accepted: 20 01 2021
pubmed: 1 2 2021
medline: 13 4 2021
entrez: 31 1 2021
Statut: ppublish

Résumé

COVID-19 is a global health threat with a huge number of confirmed cases and deaths all over the world. Human-to-human transmission via respiratory droplets and contact with aerosol-infected surfaces are the major routes of virus spread. Because SARS-CoV-2 can remain in the air and on surfaces from several hours to several days, disinfection of frequently touched surfaces and critical rooms, in addition to observing individual hygiene tips, is required to reduce the virus spreading. Here we report on an investigation into the use of gaseous ozone as a potentially effective sanitizing method against the new coronavirus.

Identifiants

pubmed: 33516798
pii: S0195-6701(21)00032-3
doi: 10.1016/j.jhin.2021.01.014
pmc: PMC7842195
pii:
doi:

Substances chimiques

Aerosols 0
Ozone 66H7ZZK23N

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-36

Informations de copyright

Copyright © 2021 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Références

Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32568661
Int J Infect Dis. 2020 Nov;100:476-482
pubmed: 32949774
Infez Med. 2020 Ahead of print Jun 1;28(2):185-191
pubmed: 32275260
mSphere. 2020 Jul 1;5(4):
pubmed: 32611701
Lancet Microbe. 2020 May;1(1):e10
pubmed: 32835322
Virol J. 2020 Oct 7;17(1):145
pubmed: 33028356
Transbound Emerg Dis. 2021 Mar;68(2):296-312
pubmed: 32603505

Auteurs

E Percivalle (E)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.

M Clerici (M)

P.C. di Pompeo Catelli SRL, Uggiate Trevano, Como, Italy. Electronic address: amministrazione@pompeocatelli.it.

I Cassaniti (I)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.

E Vecchio Nepita (E)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.

P Marchese (P)

Safety Bio Life SRL, Albuzzano, Pavia, Italy.

D Olivati (D)

Safety Bio Life SRL, Albuzzano, Pavia, Italy.

C Catelli (C)

P.C. di Pompeo Catelli SRL, Uggiate Trevano, Como, Italy.

A Berri (A)

Safety Bio Life SRL, Albuzzano, Pavia, Italy.

F Baldanti (F)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.

P Marone (P)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.

R Bruno (R)

Infection Diseases Department, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.

A Triarico (A)

Medical Direction, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.

P Lago (P)

Clinical Engineering Department, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, ITALY; Industrial and Information Engineering Department, University of Pavia, Pavia, ITALY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH